BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Influenza
,
Prostate
,
Metabolism of nitric oxide
,
Valproic acid
,
rs7903146
,
NEUROG3
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
CD40
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Superior cervical ganglion
Atrioventricular node
Ciliary ganglion
Skeletal muscle psoas
Appendix
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Bacterial infection due to Bacillus
Salmonella infection
Bordetellosis
Disease due to Trypanosomatidae
Listeriosis
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
2-methylthio-ATP
IgG2A
cabazitaxel
Secobarbital
Immunotoxins
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
PHF23
PPP2R3C
PTPA
CDC42
RHOC
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
CD40-CD40L in Neurological Disease.
Importance of CD40/CD40 dyad in the course of infection with Trypanosoma cruzi: Impact of its inhibi…
CD40-CD40L Blockade: Update on Novel Investigational Therapeutics for Transplantation.
A Polyvalent Peptide CD40 Nanoagonist for Targeted Modulation of Dendritic Cells and Amplified Cance…
Phase 1 dose-escalation study of SEA-CD40: a non-fucosylated CD40 agonist, in advanced solid tumors …
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Safety Study of SEA-CD40 in Cancer Patients
FLT3 Ligand, CD40 Agonist Antibody, and Stereotactic Radiotherapy
A Study of SEA-CD40 Given With Other Drugs in Cancers
CD40 Ligand Expressing MSLN-CAR T Cell Therapy in MSLN Positive Advanced/Metastatic Solid Tumors
A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ